Search For "corbevax"
Decision on mixing, matching of COVID-19 vaccine booster dose will be base
Updated : 4 years ago IST
New Delhi [India], March 3 (ANI): The Union Health Ministry on Thursday said that any decision on the mixing and matching of the booster dose of COVID-19 vaccines will be taken based on science.
Read More
CDL Kasauli clears almost 6.5 crore doses of Corbevax: Sources
Updated : 4 years, 1 month ago IST
New Delhi [India], February 22 (ANI): The Central Drugs Laboratory (CDL), Kasauli, has cleared almost 6.5 crore doses of Biological E's COVID-19 vaccine Corbevax based on safety, quality and efficacy parameters, sources said on Tuesday.
Read More
DCGI gives emergency use authorisation to COVID-19 vaccine Corbevax for 12
Updated : 4 years, 1 month ago IST
New Delhi [India], February 21 (ANI): Hyderabad-based pharmaceutical company Biological E on Monday received emergency use authorisation from Drugs Controller General of India (DCGI) for its COVID-19 vaccine Corbevax for the 12 to 18 age group.
Read More
Corbevax COVID vaccine is safe, offers high antibody levels: NTAGI chief
Updated : 4 years, 1 month ago IST
New Delhi [India], February 15 (ANI): India's third homegrown COVID-19 vaccine Corbevax is safe and offers good immunogenicity and higher antibody levels than some other vector vaccines, said Dr N K Arora, Chairman, India's COVID-19 Working group of National Technical Advisory Group on immun
Read More
SEC recommends COVID-19 vaccine Corbevax for 12-18 year age group: Sources
Updated : 4 years, 1 month ago IST
New Delhi [India], February 15 (ANI): The Drugs Controller General of India (DCGI)'s Subject Expert Committee (SEC) has recommended Emergency Use Authorization to Hyderabad-based pharmaceutical company Biological E's COVID-19 vaccine, Corbevax, for the age group 12 to 18 years subject to
Read More
Centre has placed purchase order for 5 crore Corbevax COVID-19 vaccine dos
Updated : 4 years, 1 month ago IST
New Delhi [India], February 5 (ANI): The Central government has placed an order with Hyderabad based Pharmaceutical company Biological E for five crore doses of 'Corbevax' COVID-19 vaccine with each dose costing Rs 145, said sources.
Read More
Discussions underway for WHO approval for Corbevax COVID-19 vaccine, says
Updated : 4 years, 2 months ago IST
Houston [US], December 31 (ANI): Corbevax, a 'recombinant protein sub-unit' vaccine developed by Texas-based vaccine developers, was recently granted emergency approval by the Indian government and will be manufactured by the Hyderabad-based company Biological E, one of the world's largest v
Read More
Dr Dangs Lab as central lab conducted tests in all three trial phases of C
Updated : 4 years, 2 months ago IST
New Delhi [India], December 29 (ANI): With the Drug Controller General of India (DCGI) approving two new COVID-19 vaccines and one anti-viral drug for emergency use on Tuesday, Dr Arjun Dang, CEO, Dr Dangs Lab, welcomed the announcement and said they feel immensely proud "to have been a p
Read More
Affordable, effective COVID-19 vaccine Corbevax to be especially useful in
Updated : 4 years, 2 months ago IST
Houston [US], December 29 (ANI): Texas Children's Hospital and Baylor College of Medicine announced on Tuesday (local time) that Corbevax, a protein sub-unit COVID-19 vaccine, whose technology was created and engineered at its Center for Vaccine Development (CVD), has received Emergency Use
Read More
Biological E gets approval to conduct trials of Corbevax as booster dose
Updated : 4 years, 2 months ago IST
New Delhi [India], December 29 (ANI): The Drug Controller General of India (DCGI) has given approval to the Hyderbad-based pharmaceutical company Biological E to conduct phase 3 clinical trials of its COVID-19 vaccine Corbevax as a booster dose, said sources.
Read More
Centre clears two new COVID vaccines, one antiviral drug; manufacturers we
Updated : 4 years, 2 months ago IST
New Delhi [India], December 28 (ANI): After the Union Health Ministry cleared two new COVID-19 vaccines and one anti-viral drug for emergency use on Tuesday, vaccine manufacturers welcomed the announcement and said that this would support the patients across India.
Read More
Centre approves two indigenously developed COVID vaccines, one anti-viral
Updated : 4 years, 2 months ago IST
New Delhi [India], December 28 (ANI): Union Minister of Health and Family Welfare Mansukh Mandaviya on Tuesday announced the approval of two new indigenously developed vaccines and one anti-viral drug for the treatment of the adult patients of COVID-19 having a "high risk of progression o
Read More